Wolff-Parkinson-White (WPW) syndrome with PSVT.
Female 47 years old, with a shake of the EKG to see. After the second treatment is the idea that the reason for the shake of the EKG is the first of what And the treatment here?
Ecg 1
Ecg 2
The EKG is the first one with paroxysmal supraventricular tachycardia (PSVT).
After the treatment a second time for delivery. Wolff-Parkinson-White (WPW) syndrome.
Wolff-Parkinson-White (WPW) syndrome is a congenital anomaly.
This occurs because the electrical signal from atrium is transmitted to the ventricle through the accessory pathway (which is the accessory pathway is the Bundle of Kent or the Kent Bundle in WPW syndrome) and the AV node, but the signal will not be delayed in the accessory pathway that. electrical signal through the accessory pathway to the ventricle and stimulating. depolarization of the ventricle slowly (ventricular preexcitation) before the signal from the AV node to reach on the ECG is an important characteristic of the QRS complex, the larger the delta wave occurs because the electrical signal into the ventricle by accessory pathway does not. Purkinje fibers, making the signal more slowly, so the QRS complex is wider than normal. The main problem in patients with WPW syndrome is an electrical signal from the accessory pathway can also return to the atrium through the AV node and cause antidromic AV reentrant tachycardia in patients with this condition, heart rate, 150-250. per minute in patients with WPW may be fatal if cardiac arrhythmias and atrial fibrillation or flutter in conjunction with the adoption of the electrical signal from atrium to ventricle will not be delayed or accessory pathway to the electrical signals pass. ventricle and the rapid increase of the compression of the ventricle is very high throughout life threatening.
Treatment
- Patients with no symptoms will be evaluated periodically, Radiofrequency (RF) ablation as first-line treatment in patients with symptoms. The drug is used in the case of RF ablation have not been made or the patient refuses to do, and patients may have severe complications from the RF ablation.
- Drug Ic and class III antiarrhythmic. The slow down in the accessory pathway, which inhibits the occurrence of PSVT. But if the patient has a history of atrial fibrillation or atrial flutter was associated with AV nodal blocking drugs should be used.
- The digoxin is contraindicated in patients with WPW syndrome because of the WPW. death syndrome. Most are related to the use of digoxin.
Ventricular preexcitation and the Atrioventricular reentant tachycardia.
Comments
Post a Comment